Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Averica Award for Supercritical Fluid Chromatography Announced

Published: Monday, July 15, 2013
Last Updated: Monday, July 15, 2013
Bookmark and Share
Pfizer’s Bill Farrell honored for contributions to preparative SFC enabling fast, scalable isolation and purification.

“We are delighted that the first recipient of the Averica Award is Bill Farrell, who with his team at Pfizer has been central in helping to make SFC such a powerful technology,” noted Dr. Kiplinger. “Bill has had a substantial impact on the design of preparative SFC systems, including his critical contributions to stationary phase development, and he has played a major influential role at relevant scientific meetings. At Averica Discovery, we rely on preparative SFC to provide our customers a scalable approach to chromatographic isolation on an accelerated timescale, giving us the opportunity to appreciate Bill’s contributions to the field daily.”  

SFC is used for the analysis and purification of low to moderate molecular weight molecules and for chiral separations. Carbon dioxide-based SFC achieves high resolution, yet is faster and more efficient than liquid-based HPLC. Importantly, SFC eliminates the need for organic chemical solvents and recycles CO2, making it an environmentally conscious, “greener” alternative. The increasingly prominent role of SFC technology is evidenced by the fact that the number of SFC-related articles in chromatography journals has risen 4-5 fold over the past decade.

Mr. Farrell commented, "This is really an honor. I've been lucky to work with colleagues and collaborators who contributed a passion for science and chromatography to many different projects, and I'm especially grateful that the body of our work is being recognized as a whole."  As part of the Averica Award, Mr. Farrell received an honorarium and will deliver a keynote presentation at the SFC 2013 conference today.

The Averica Award is given annually at the International Conference on Packed Column SFC organized by the Green Chemistry Group. Recipients are chosen from submitted nominees, based on the novelty and impact of their work in the field of preparative SFC. 

Separately, Averica Discovery Services announced that it will be moving to a larger facility at the end of the month. The new facility, located at 260 Cedar Hill Street, Marlborough, MA, 01752, essentially doubles the company’s space.  

Dr. Kiplinger added, “We are proud that our commitment to providing exceptional, technologically advanced services has enabled us to double our business over the past year. We look forward to further strong growth based in our new facilities. And now we're even closer to our many customers in the greater Boston life sciences community.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!